Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, PO Box 2040, 3000 CA, Rotterdam, the Netherlands.
Department of Neurology, Alzheimer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Alzheimers Res Ther. 2023 May 12;15(1):94. doi: 10.1186/s13195-023-01240-7.
Neuropsychiatric symptoms (NPS) are prevalent in the early clinical stages of Alzheimer's disease (AD) according to proxy-based instruments. Little is known about which NPS clinicians report and whether their judgment aligns with proxy-based instruments. We used natural language processing (NLP) to classify NPS in electronic health records (EHRs) to estimate the reporting of NPS in symptomatic AD at the memory clinic according to clinicians. Next, we compared NPS as reported in EHRs and NPS reported by caregivers on the Neuropsychiatric Inventory (NPI).
Two academic memory clinic cohorts were used: the Amsterdam UMC (n = 3001) and the Erasmus MC (n = 646). Patients included in these cohorts had MCI, AD dementia, or mixed AD/VaD dementia. Ten trained clinicians annotated 13 types of NPS in a randomly selected training set of n = 500 EHRs from the Amsterdam UMC cohort and in a test set of n = 250 EHRs from the Erasmus MC cohort. For each NPS, a generalized linear classifier was trained and internally and externally validated. Prevalence estimates of NPS were adjusted for the imperfect sensitivity and specificity of each classifier. Intra-individual comparison of the NPS classified in EHRs and NPS reported on the NPI were conducted in a subsample (59%).
Internal validation performance of the classifiers was excellent (AUC range: 0.81-0.91), but external validation performance decreased (AUC range: 0.51-0.93). NPS were prevalent in EHRs from the Amsterdam UMC, especially apathy (adjusted prevalence = 69.4%), anxiety (adjusted prevalence = 53.7%), aberrant motor behavior (adjusted prevalence = 47.5%), irritability (adjusted prevalence = 42.6%), and depression (adjusted prevalence = 38.5%). The ranking of NPS was similar for EHRs from the Erasmus MC, although not all classifiers obtained valid prevalence estimates due to low specificity. In both cohorts, there was minimal agreement between NPS classified in the EHRs and NPS reported on the NPI (all kappa coefficients < 0.28), with substantially more reports of NPS in EHRs than on NPI assessments.
NLP classifiers performed well in detecting a wide range of NPS in EHRs of patients with symptomatic AD visiting the memory clinic and showed that clinicians frequently reported NPS in these EHRs. Clinicians generally reported more NPS in EHRs than caregivers reported on the NPI.
根据代理工具,神经精神症状(NPS)在阿尔茨海默病(AD)的早期临床阶段普遍存在。对于临床医生报告的哪些 NPS 知之甚少,并且他们的判断是否与代理工具一致。我们使用自然语言处理(NLP)来对电子健康记录(EHR)中的 NPS 进行分类,以估计根据临床医生在记忆诊所中对有症状的 AD 患者的 NPS 报告。接下来,我们比较了 EHR 中报告的 NPS 和护理人员在神经精神病学问卷(NPI)上报告的 NPS。
我们使用了两个学术记忆诊所队列:阿姆斯特丹 UMC(n=3001)和伊拉斯谟 MC(n=646)。这些队列中的患者包括 MCI、AD 痴呆或混合 AD/VaD 痴呆。十名经过培训的临床医生在阿姆斯特丹 UMC 队列的 n=500 名 EHR 随机选择的训练集中和伊拉斯谟 MC 队列的 n=250 名 EHR 测试集中注释了 13 种 NPS。对于每种 NPS,都训练了一个广义线性分类器,并进行了内部和外部验证。对每个分类器的不完美敏感性和特异性进行了调整,以调整 NPS 的患病率估计。在一个亚样本(59%)中进行了在 EHR 中分类的 NPS 与在 NPI 上报告的 NPS 的个体内比较。
分类器的内部验证性能非常出色(AUC 范围:0.81-0.91),但外部验证性能下降(AUC 范围:0.51-0.93)。EHR 中 NPS 的患病率在阿姆斯特丹 UMC 中很高,尤其是冷漠(调整后的患病率=69.4%)、焦虑(调整后的患病率=53.7%)、异常运动行为(调整后的患病率=47.5%)、易怒(调整后的患病率=42.6%)和抑郁(调整后的患病率=38.5%)。伊拉斯谟 MC 的 EHR 中的 NPS 排名相似,尽管由于特异性低,并非所有分类器都获得了有效的患病率估计值。在两个队列中,EHR 中分类的 NPS 与 NPI 上报告的 NPS 之间的一致性很小(所有kappa 系数均<0.28),EHR 中报告的 NPS 明显多于 NPI 评估。
NLP 分类器在检测接受记忆诊所就诊的有症状 AD 患者的 EHR 中的广泛 NPS 方面表现出色,并表明临床医生经常在这些 EHR 中报告 NPS。与护理人员在 NPI 上的报告相比,临床医生通常在 EHR 中报告更多的 NPS。